Variant Bio is using the enormous power of human genetic diversity to discover a new generation of therapeutics.
Variant Bio is searching the globe for people who are medical or genomic outliers in order to identify the genes and pathways driving these traits, with the goal of uncovering the targets for tomorrow’s drugs and advancing much-needed therapies to market.
- Akhila Kosaraju
- Kaja Wasik
- Stephane Castel
- We @VariantBio will always stand in solidarity against racism and injustice. #BlackLivesMatter
- Journalist Ashlee Vance (@valleyhack) from Bloomberg Businessweek highlights @VariantBio's new CEO, @AndrewFarnum,… https://t.co/OnqNvWMQX3
- Great profile of us in @BW. @valleyhack captured the most important parts of our story, including the unique way we… https://t.co/TCkK1o0GGC